REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
AKTIENPREIS
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionCreative Planning
Latest Disclosed Ownership30,001 shares
Latest Disclosed Value $ 251,408
Creative Planning reports 9.15% decrease in ownership of RB0 / REGENXBIO Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 30,001 shares of REGENXBIO Inc. (DE:RB0) valued at $207,007 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 33,021 shares of REGENXBIO Inc.. This represents a change in shares of -9.15% during the quarter. The current value of the position is $186,006 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F REGENXBIO COM 75901B107 30,001 -3,020 -9.15 251 -47.16 0.0002
2026-02-17 2025-12-31 13F REGENXBIO COM 75901B107 33,021 7,108 27.43 476 90.00 0.0003
2025-11-14 2025-09-30 13F REGENXBIO COM 75901B107 25,913 11,293 77.24 250 108.33 0.0002
2025-08-08 2025-06-30 13F REGENXBIO COM 75901B107 14,620 -1,514 -9.38 120 4.35 0.0001
2025-05-15 2025-03-31 13F REGENXBIO COM 75901B107 16,134 16,134 115 0.0001
2020-05-05 2020-03-31 13F REGENXBIO COM 75901B107 0 -13,200 -100.00 0 -100.00
2020-01-30 2019-12-31 13F REGENXBIO COM 75901B107 13,200 -200 -1.49 541 13.42 0.0016
2019-11-01 2019-09-30 13F REGENXBIO COM 75901B107 13,400 -250 -1.83 477 -31.95 0.0016
2019-07-26 2019-06-30 13F REGENXBIO COM 75901B107 13,650 9,900 264.00 701 226.05 0.0024
2019-04-24 2019-03-31 13F REGENXBIO COM 75901B107 3,750 3,750 215 0.0008
2019-02-12 2018-12-31 13F/A-1 REGENXBIO COM 75901B107 0 -3,650 -100.00 0 -100.00
2018-10-25 2018-09-30 13F REGENXBIO COM 75901B107 3,650 -300 -7.59 276 -2.47 0.0010
2018-07-20 2018-06-30 13F REGENXBIO COM 75901B107 3,950 3,950 283 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.